In a remarkable financial turn, Torrent Pharmaceuticals has disclosed a staggering 30% rise in after-tax profit for the September quarter, reaching ₹591 crore. This impressive growth is attributed to thriving sales in various markets, which escalated their total revenue to ₹3,302 crore.
RR Kabel shares jump 10% as Q1 PAT surges 129% YoY, Ebitda doubles
RR Kabel reported a strong June-quarter performance, with profit after tax surging 129% year-on-year and Ebitda nearly doubling, driven by robust growth in its Wires